10/8/2007

Drug giants Pfizer and Johnson & Johnson secured top posts in the list of global research and development investors, a European Commission report revealed. The annual European Union international scoreboard of corporate R&D spending found biotech and pharmaceutical companies increased spending by 15.7% in 2006.

Related Summaries